In vivo danner infliximab hurtigt stabile komplekser med human TNFα, en proces der svarer til tabet af TNFα bioaktivitet.
In vivo, infliximab rapidly forms stable complexes with human TNFα, a process that parallels the loss of TNFα bioactivity.